{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:55:13Z","timestamp":1776120913645,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU107-ASIA-24"],"award-info":[{"award-number":["CMU107-ASIA-24"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU103-ASIA-21"],"award-info":[{"award-number":["CMU103-ASIA-21"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","award":["CMRC-CHM-4"],"award-info":[{"award-number":["CMRC-CHM-4"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.abb.2026.110782","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T23:54:00Z","timestamp":1772841240000},"page":"110782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Physalin A interferes with cell cycle in human oral squamous carcinoma cells via DNA topoisomerase II\/ATM\/ATR\/Chk signaling for G2\/M phase arrest"],"prefix":"10.1016","volume":"780","author":[{"given":"Yi-Ping","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuang-Chi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueh-Hsiung","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Chiang","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chung","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Shih","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaw-Chyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8333-7519","authenticated-orcid":false,"given":"Fu-Shin","family":"Chueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Tsong","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.abb.2026.110782_bib1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/00220345241307894","article-title":"Deciphering the premetastatic lymphatic niche of oral squamous cell carcinoma","volume":"104","author":"Cao","year":"2025","journal-title":"J. Dent. Res."},{"issue":"19","key":"10.1016\/j.abb.2026.110782_bib2","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.3390\/cancers14194967","article-title":"Challenges in the early diagnosis of oral cancer, evidence gaps and strategies for improvement: a scoping review of systematic reviews","volume":"14","author":"Gonz\u00e1lez-Moles","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.abb.2026.110782_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/00220345241297122","article-title":"Targeting epigenetic dysregulations in head and neck squamous cell carcinoma","volume":"104","author":"Li","year":"2025","journal-title":"J. Dent. Res."},{"issue":"8","key":"10.1016\/j.abb.2026.110782_bib4","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/jcm10081658","article-title":"Potential non-invasive biomarkers for early diagnosis of oral squamous cell carcinoma","volume":"10","author":"Dikova","year":"2021","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.abb.2026.110782_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1177\/00220345231165209","article-title":"PD-1 carried on small extracellular vesicles leads to OSCC metastasis","volume":"102","author":"Zhang","year":"2023","journal-title":"J. Dent. Res."},{"issue":"7338","key":"10.1016\/j.abb.2026.110782_bib6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature09791","article-title":"Chromosome length influences replication-induced topological stress","volume":"471","author":"Kegel","year":"2011","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.abb.2026.110782_bib7","doi-asserted-by":"crossref","first-page":"15182","DOI":"10.1073\/pnas.1922072117","article-title":"Uncoupling DNA damage from chromatin damage to detoxify doxorubicin","volume":"117","author":"Qiao","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.abb.2026.110782_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.761379","article-title":"The molecular basis and therapeutic aspects of cisplatin resistance in oral squamous cell carcinoma","volume":"11","author":"Cheng","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.abb.2026.110782_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejphar.2017.10.043","article-title":"Molecular mechanism of doxorubicin-induced cardiomyopathy - an update","volume":"818","author":"Renu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.abb.2026.110782_bib10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.fct.2008.12.013","article-title":"Oxidative stress involvement in physalis angulata-induced apoptosis in human oral cancer cells","volume":"47","author":"Lee","year":"2009","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.abb.2026.110782_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115115","article-title":"Physalin A attenuates inflammation through down-regulating c-Jun NH2 kinase Phosphorylation\/activator protein 1 activation and up-regulating the antioxidant activity","volume":"402","author":"Lin","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1-2","key":"10.1016\/j.abb.2026.110782_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11010-016-2686-1","article-title":"Physalin A induces G2\/M phase cell cycle arrest in human non-small cell lung cancer cells: involvement of the p38 MAPK\/ROS pathway","volume":"415","author":"Kang","year":"2016","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.abb.2026.110782_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12906-019-2511-y","article-title":"Physalin A regulates the Nrf2 pathway through ERK and p38 for induction of detoxifying enzymes","volume":"19","author":"Shin","year":"2019","journal-title":"BMC Compl. Alternative Med."},{"issue":"5","key":"10.1016\/j.abb.2026.110782_bib14","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1021\/np400017k","article-title":"Physalin A induces apoptotic cell death and protective autophagy in HT1080 human fibrosarcoma cells","volume":"76","author":"He","year":"2013","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.abb.2026.110782_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115115","article-title":"Physalin A attenuates inflammation through down-regulating c-Jun NH2 kinase phosphorylation\/activator protein 1 activation and up-regulating the antioxidant activity","volume":"402","author":"Lin","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.abb.2026.110782_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.fct.2014.06.007","article-title":"Nitric oxide induces apoptosis and autophagy; autophagy down-regulates NO synthesis in physalin A-treated A375-S2 human melanoma cells","volume":"71","author":"He","year":"2014","journal-title":"Food Chem. Toxicol."},{"issue":"10","key":"10.1016\/j.abb.2026.110782_bib17","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1248\/bpb.34.1584","article-title":"Physalins A and B inhibit androgen-independent prostate cancer cell growth through activation of cell apoptosis and downregulation of androgen receptor expression","volume":"34","author":"Han","year":"2011","journal-title":"Biol. Pharmaceut. Bull."},{"issue":"10","key":"10.1016\/j.abb.2026.110782_bib18","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/tox.21992","article-title":"Latex of euphorbia antiquorum-induced S-phase arrest via active ATM kinase and MAPK pathways in human cervical cancer HeLa cells","volume":"30","author":"Hsieh","year":"2015","journal-title":"Environ. Toxicol."},{"issue":"4","key":"10.1016\/j.abb.2026.110782_bib19","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1142\/S0192415X19500447","article-title":"Fisetin inhibits cell proliferation through the induction of G(0)\/G(1) phase arrest and Caspase-3-Mediated apoptosis in mouse leukemia cells","volume":"47","author":"Tsai","year":"2019","journal-title":"Am. J. Chin. Med."},{"issue":"12","key":"10.1016\/j.abb.2026.110782_bib20","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1002\/tox.24393","article-title":"PEITC induces DNA damage and inhibits DNA repair-associated proteins in human retinoblastoma cells in vitro","volume":"39","author":"Hsu","year":"2024","journal-title":"Environ. Toxicol."},{"issue":"3","key":"10.1016\/j.abb.2026.110782_bib21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s11064-009-0067-9","article-title":"Danthron induced apoptosis through mitochondria- and caspase-3-dependent pathways in human brain glioblastoma multiforms GBM 8401 cells","volume":"35","author":"Lu","year":"2010","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.abb.2026.110782_bib22","first-page":"362","article-title":"Imperatorin interferes with LPS binding to the TLR4 Co-Receptor and activates the Nrf2 antioxidative pathway in RAW264.7 murine macrophage cells","volume":"10","author":"Huang","year":"2021","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.abb.2026.110782_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.abb.2026.110782_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.abb.2026.110782_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuropharm.2017.01.023","article-title":"The binding orientations of structurally-related ligands can differ; A cautionary note","volume":"119","author":"Ruepp","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.abb.2026.110782_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/01926230252824761","article-title":"Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies","volume":"30","author":"Shackelford","year":"2002","journal-title":"Toxicol. Pathol."},{"issue":"1 Pt 1","key":"10.1016\/j.abb.2026.110782_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1158\/1078-0432.CCR-0999-3","article-title":"Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice","volume":"10","author":"Tang","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"28","key":"10.1016\/j.abb.2026.110782_bib28","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1021\/bi700272u","article-title":"Topoisomerase II - drug interaction domains: identification of substituents on etoposide that interact with the enzyme","volume":"46","author":"Wilstermann","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2026.110782_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104672","article-title":"Immunotherapy in OSCC: current trend and challenges","volume":"209","author":"Gupta","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.abb.2026.110782_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","article-title":"Oral squamous cell carcinomas: state of the field and emerging directions","volume":"15","author":"Tan","year":"2023","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.abb.2026.110782_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/09603271251335220","article-title":"Physalin A induces apoptosis through conjugating with Fas-FADD cell death receptor in human oral squamous carcinoma cells and suppresses HSC-3 cell xenograft tumors in NOD\/SCID mice","volume":"44","author":"Chueh","year":"2025","journal-title":"Hum. Exp. Toxicol."},{"issue":"1","key":"10.1016\/j.abb.2026.110782_bib32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11010-021-04318-8","article-title":"Correction to: physalin A induces G2\/M phase cell cycle arrest in human non-small cell lung cancer cells: involvement of the p38 MAPK\/ROS pathway","volume":"477","author":"Kang","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.abb.2026.110782_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2018.05.017","article-title":"PARP1 promoter links cell cycle progression with adaptation to oxidative environment","volume":"18","author":"Pietrzak","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.abb.2026.110782_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2024.100185","article-title":"Functions and inhibitors of CHK1 in cancer therapy","volume":"22","author":"Jiang","year":"2024","journal-title":"Medicine in Drug Discovery"},{"key":"10.1016\/j.abb.2026.110782_bib35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12935-020-01304-w","article-title":"The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review","volume":"20","author":"Liu","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"11","key":"10.1016\/j.abb.2026.110782_bib36","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.3390\/ijms18112344","article-title":"G2\/M-Phase checkpoint adaptation and micronuclei formation as mechanisms that contribute to genomic instability in human cells","volume":"18","author":"Kalsbeek","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.abb.2026.110782_bib37","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.biopha.2018.02.094","article-title":"Physalin B induces cell cycle arrest and triggers apoptosis in breast cancer cells through modulating p53-dependent apoptotic pathway","volume":"101","author":"Wang","year":"2018","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"11","key":"10.1016\/j.abb.2026.110782_bib38","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.3390\/ijms22115754","article-title":"The involvement of ubiquitination machinery in cell cycle regulation and cancer progression","volume":"22","author":"Zou","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.abb.2026.110782_bib39","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1158\/1535-7163.MCT-14-0735-T","article-title":"Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence","volume":"14","author":"Osman","year":"2015","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.abb.2026.110782_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176968","article-title":"Dual inhibition of topoisomerase II and microtubule of podophyllotoxin derivative 5p overcomes cancer multidrug resistance","volume":"983","author":"Lv","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"38","key":"10.1016\/j.abb.2026.110782_bib41","doi-asserted-by":"crossref","first-page":"23663","DOI":"10.1073\/pnas.2008474117","article-title":"p53 drives a transcriptional program that elicits a non-cell-autonomous response and alters cell state in vivo","volume":"117","author":"Moyer","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.abb.2026.110782_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102957","article-title":"Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trial","volume":"78","author":"Koscielniak","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"6","key":"10.1016\/j.abb.2026.110782_bib43","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1042\/BST20200454","article-title":"TOP2B's contributions to transcription","volume":"49","author":"Austin","year":"2021","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.abb.2026.110782_bib44","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1080\/14756366.2020.1821676","article-title":"DNA topoisomerases as molecular targets for anticancer drugs","volume":"35","author":"Buzun","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.abb.2026.110782_bib45","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/0022034518759068","article-title":"Targeting the DNA damage response in OSCC with TP53 mutations","volume":"97","author":"Lindemann","year":"2018","journal-title":"J. Dent. Res."},{"issue":"1","key":"10.1016\/j.abb.2026.110782_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13045-019-0733-6","article-title":"Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand","volume":"12","author":"Mei","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.abb.2026.110782_bib47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1039\/C6MD00439C","article-title":"ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells","volume":"8","author":"Ronco","year":"2017","journal-title":"Medchemcomm"},{"issue":"3","key":"10.1016\/j.abb.2026.110782_bib48","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/path.4528","article-title":"Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma","volume":"236","author":"Baranski","year":"2015","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.abb.2026.110782_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12906-019-2511-y","article-title":"Physalin A regulates the Nrf2 pathway through ERK and p38 for induction of detoxifying enzymes","volume":"19","author":"Shin","year":"2019","journal-title":"BMC Compl. Alternative Med."},{"issue":"9","key":"10.1016\/j.abb.2026.110782_bib50","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.celrep.2015.05.004","article-title":"MERIT40 is an akt substrate that promotes resolution of DNA damage induced by chemotherapy","volume":"11","author":"Brown","year":"2015","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.abb.2026.110782_bib51","first-page":"3333","article-title":"Nrf2-dependent antioxidant response mediated the protective effect of tanshinone IIA on doxorubicin-induced cardiotoxicity","volume":"16","author":"Guo","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"13","key":"10.1016\/j.abb.2026.110782_bib52","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1074\/jbc.M111.312694","article-title":"Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis","volume":"287","author":"Niture","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"43","key":"10.1016\/j.abb.2026.110782_bib53","doi-asserted-by":"crossref","first-page":"30690","DOI":"10.1074\/jbc.274.43.30690","article-title":"Yeast topoisomerase II is inhibited by etoposide after hydrolyzing the first ATP and before releasing the second ADP","volume":"274","author":"Morris","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2026.110782_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104665","article-title":"Rahisuddin, pyrazoline analogs as potential anticancer agents and their apoptosis, molecular docking, MD simulation, DNA binding and antioxidant studies","volume":"108","author":"Rana","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"9","key":"10.1016\/j.abb.2026.110782_bib55","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1586\/era.10.108","article-title":"DMBA-induced hamster buccal pouch carcinoma and VX2-induced rabbit cancer as a model for human oral carcinogenesis","volume":"10","author":"Chen","year":"2010","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"5","key":"10.1016\/j.abb.2026.110782_bib56","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/jclinpath-2020-207302","article-title":"Conjunctival squamous intraepithelial neoplasia and its differential diagnosis","volume":"75","author":"Reese","year":"2022","journal-title":"J. Clin. Pathol."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986126000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986126000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:08:09Z","timestamp":1776118089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986126000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":56,"alternative-id":["S0003986126000536"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2026.110782","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physalin A interferes with cell cycle in human oral squamous carcinoma cells via DNA topoisomerase II\/ATM\/ATR\/Chk signaling for G2\/M phase arrest","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2026.110782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110782"}}